Precise Calculation of Complex Radioactive Decay Chains

This thesis documents a new approach to investigate the gamma radiation activity of the fission products of three different fuels (U-235, U-238, and U-239) exposed to three different incident neutron energy spectra (thermal, fast spectrum, and high energies). An application of the exponential moments function is used with a transmutation matrix in the calculation of complex radioactive decay chains to achieve greater precision than can be attained through current methods. The result of this research is a code which can calculate the decay products from complex radioactive decay chains with a high degree of precision while quantifying the uncertainty in gamma activity due to uncertainties in the isotope properties

Pseudorapidity Distribution of Charged Particles in PbarP Collisions at root(s)= 630GeV

Using a silicon vertex detector, we measure the charged particle pseudorapidity distribution over the range 1.5 to 5.5 using data collected from PbarP collisions at root s = 630 GeV. With a data sample of 3 million events, we deduce a result with an overall normalization uncertainty of 5%, and typical bin to bin errors of a few percent. We compare our result to the measurement of UA5, and the distribution generated by the Lund Monte Carlo with default settings. This is only the second measurement at this level of precision, and only the second measurement for pseudorapidity greater than 3.Comment: 9 pages, 5 figures, LaTeX format. For ps file see http://hep1.physics.wayne.edu/harr/harr.html Submitted to Physics Letters

Comparison of Hadronic Interaction Models at Auger Energies

The three hadronic interaction models DPMJET 2.55, QGSJET 01, and SIBYLL 2.1, implemented in the air shower simulation program CORSIKA, are compared in the energy range of interest for the Pierre Auger experiment. The model dependence of relevant quantities in individual hadronic interactions and air showers is investigated.Comment: Contribution to XII Int. Symp. on Very High Energy Cosmic Ray Interactions, 4 pages, 8 figure

Increasing carbon sequestration of working prairie by reducing invasive species in a fire and grazing system

The investigators looked at one method for curbing invasive species that limit carbon sequestration potential for tallgrass prairie stands. They also learned that grasslands dominated by either warm-season, cool-season, or mixed stands are likely equal in their carbon sequestration potential

Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease: A meta-analysis of randomized controlled trials

Aims To evaluate whether stents as compared to balloon angioplasty reduce mortality in patients with non-acute coronary artery disease. Methods and results We identified randomized controlled trials comparing stents to balloon angioplasty for the treatment of non-acute coronary artery disease by searching major medical databases from 1979 to March 2002. Two independent reviewers selected and extracted data from trials that had to report data on death and myocardial infarction. Nineteen trials, with a total of 8004 patients, fulfilled our inclusion criteria. For 1000 patients treated with stents rather than balloon angioplasty, 3 (95% CI 0-6), 5 (95% CI 0-9), and 6 (95% CI -1-12) additional lives were saved at 30 days, 6 and 12 months. At 12 months, for 1000 patients treated with stents rather than balloon angioplasty 46 (95% CI 25-66) additional target vessel revascularizations were avoided, but 25 (95% CI 15-34) additional bleeding complications with need for blood transfusion or surgical intervention occurred. In sensitivity analysis 11 (95% CI 2-20) and 2 (95% CI -4-7) deaths were avoided per 1000 patients treated with stents rather than PTCA in trials that routinely used compared to trials that did not use glycoprotein IIb/IIIa inhibitors. Conclusion In non-acute coronary disease stents may reduce overall mortality, but this benefit seems to be limited to stents used in conjunction with glycoprotein IIb/IIIa inhibitors. Stents compared to PTCA reduce target vessel revascularizations, but increase the risk of bleeding complication

Averages of b-hadron Properties at the End of 2005

This article reports world averages for measurements on b-hadron properties obtained by the Heavy Flavor Averaging Group (HFAG) using the available results as of at the end of 2005. In the averaging, the input parameters used in the various analyses are adjusted (rescaled) to common values, and all known correlations are taken into account. The averages include lifetimes, neutral meson mixing parameters, parameters of semileptonic decays, branching fractions of B meson decays to final states with open charm, charmonium and no charm, and measurements related to CP asymmetries

Cosmic Ray particle production

The status of some popular models to simulate hadronic and nuclear interactions at Cosmic Ray energies is reviewed. The models predict the rise of all the hadronic and nuclear cross sections with energy and a smooth (logarithmic) rise of average multiplicities, rapidity plateaus and average transverse momenta with the energy. The importance is stressed to put more effort into the models and especially a better understanding of the minijet component at the highest energies. Likewise, experimental data on particle production are needed at the highest possible energies, to guide the models.Comment: 13 pages, LATEX, espcrc2.sty, 21 figures included as ps file

Toxic Epidermal Necrolysis after Pemetrexed and Cisplatin for Non-Small Cell Lung Cancer in a Patient with Sharp Syndrome

Background: Pemetrexed is an antifolate drug approved for maintenance and second-line therapy, and, in combination with cisplatin, for first-line treatment of advanced nonsquamous non-small cell lung cancer. The side-effect profile includes fatigue, hematological and gastrointestinal toxicity, an increase in hepatic enzymes, sensory neuropathy, and pulmonary and cutaneous toxicity in various degrees. Case Report: We present the case of a 58-year-old woman with history of Sharp's syndrome and adenocarcinoma of the lung, who developed toxic epidermal necrolysis after the first cycle of pemetrexed, including erythema, bullae, extensive skin denudation, subsequent systemic inflammation and severe deterioration in general condition. The generalized skin lesions occurred primarily in the previous radiation field and responded to immunosuppressive treatment with prednisone. Conclusion: Although skin toxicity is a well-known side effect of pemetrexed, severe skin reactions after pemetrexed administration are rare. Caution should be applied in cases in which pemetrexed is given subsequent to radiation therapy, especially in patients with pre-existing skin diseases